Poland· PL-100087245
Exoderil
A naftifine product containing naftifini hydrochloridum, registered in Poland by Sandoz GmbH. The same ATC class is registered in 4 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Naftifine is registered in 4 of 19 countries.
Countries holding a registration under ATC D01AE22 (naftifine), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 3 of them publish a price we can compare per daily dose
Naftifine · ATC D01AE22
4 / 19 countries
- Czechiaprice
- Germany
- Polandprice
- United Statesprice
The record
At a glance
URPL (Poland)- Active substance
- Naftifini hydrochloridum
- Manufacturer
- Sandoz GmbH
- Country
- Poland (PL)
- ATC code
- D01AE22
- ATC class
- Naftifine
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05909990422319
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Naftifine in 3 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaEXODERILSandoz GmbH, Kundl
- United StatesNaftifine HydrochlorideSun Pharmaceutical Industries, Inc.
- GermanyExoderilMedice Pharma Gmbh & Co. Kg
Authorised across Europe · EMA
The same active substance is authorised in 12 EEA countries. Names it is sold under:
- Austria · Exoderil
- Bulgaria · Exoderil, Екзодерил
- Czechia · Exoderil, Videril
- Germany · Exoderil
- Estonia · Exoderil
- Croatia · Atlex 10 Mg/Ml Sprej Za Kožu, Exoderil
- Hungary · Exoderil
- Italy · Suadian
- Lithuania · Exoderil
- Latvia · Exoderil
- Romania · Exoderil, Naftifina Atb
- Slovenia · Exoderil
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/3eb460f7-c8a6-4fc5-9d39-6369f534a988 GET /v1/drugs/3eb460f7-c8a6-4fc5-9d39-6369f534a988?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Krem",
"source": "urpl",
"strength": "10 mg/g",
"packaging": "05909990422319 ¦ OTC ¦ 13552\n1 tuba 15 g",
"substance": "Naftifini hydrochloridum 10 mg",
"common_name": "Naftifini hydrochloridum",
"pl_product_id": "100087245",
"pozwolenie_nr": "04223",
"auth_procedure": "NAR",
"authorisation_validity": "2024-09-10"
}See everything about naftifine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.